Scott Rocklage is an American entrepreneur who aims to create medicines that would help cure diseases and ailments. He graduated from the University of California, Berkeley where he received his Bachelor of Science Degree in Chemistry, and then went to the Massachusetts Institute of Technology where he earned his PhD in Chemistry.
His research back then was conducted at the laboratory of Richard Schrock, a Chemistry Nobel Prize winner. Scott Rocklage has worked with many companies in the past, and he held different positions.
He has been appointed as a chairman, as a chief executive officer, as a president, as a board chairman, and other executive positions in different pharmaceutical companies – Cubist Pharmaceuticals, Nycomed Salutar, Salutar and Catalytica, Relypsa, Novira, Ilypsa, Miikana and Semprus among others.
Today, he is still handling positions in different companies, mainly as the board chairman, as in the case of Renovia, Kinestral and Cidara, and as a board member, as in the case of Epirus and Pulmatrix.
Back in 2003, Scott decided to open his own business, named 5 AM Ventures. He held positions in his company such as a venture partner, and later on as a managing partner. He already has 30 strong year career in the health industry, and his experience working with his particular field has helped him develop 5 AM Ventures.
Because of his knowledge about the chemistry of pharmaceutical drugs, three drug applications were permitted by FDA: Omniscan, Teslascan and Cubicin. Scott Rocklage is also credited with greater than 30 US patents, and more than a hundred peer reviewed publications. Read more: Scott Racklage | Bloomberg
5 AM Ventures is based in Boston Massachusetts, and according to Scott Rocklage, he named his company as such because they are still new to the industry. He thinks that 5 AM is an early time, and it fits their description of still being in an early stage.
Scott Rocklage uses his spare time studying and reading new things. He is working with a vast network of scientists around the globe that are conducting researches about medicines, and he is hoping that one day, every disease in the world can be curable.